Edition:
United Kingdom

STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

15.45USD
7:09pm GMT
Change (% chg)

$0.05 (+0.32%)
Prev Close
$15.40
Open
$15.55
Day's High
$15.55
Day's Low
$15.35
Volume
9,531
Avg. Vol
38,402
52-wk High
$17.60
52-wk Low
$8.95

Chart for

About

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $563.19
Shares Outstanding(Mil.): 41.11
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.60
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017

* STAAR SURGICAL SEES ‍DOUBLE DIGIT REVENUE GROWTH IN FULL YEAR 2018 OVER 2017 AND ICL UNIT GROWTH RANGE 15% TO 20% FOR 2018​ Source text (http://bit.ly/2AFxyde) Further company coverage:

08 Jan 2018

BRIEF-Staar Surgical reports Q3 earnings per share $0.03

* Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S

08 Nov 2017

BRIEF-Staar surgical appoints Scott Barnes, M.D. as chief medical officer

* Staar surgical appoints Scott Barnes, M.D. as chief medical officer Source text for Eikon: Further company coverage:

02 Oct 2017

BRIEF-Staar Surgical names Deborah Andrews as CFO

* Deborah Andrews, interim CFO, has agreed to resume her role as Chief Financial Officer for company​ Source text for Eikon: Further company coverage:

28 Sep 2017

Earnings vs. Estimates